Scientists re-engineer Patients' own cells to fight aggressive blood cancers
NCT ID NCT07300683
Summary
This early-stage trial is testing a new personalized cell therapy for children and adults with T-cell leukemia or lymphoma that has come back or not responded to standard treatments. Doctors will collect a patient's own immune cells, modify them in a lab to better target the cancer, and then infuse them back into the patient. The main goals are to see if this process is safe and to find the best dose for future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University College London Hospitals
RECRUITINGLondon, United Kingdom
Conditions
Explore the condition pages connected to this study.